Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Nektar Announces Topline Data from HAP Study for NKTR-181

NKTR-181 shows significantly less abuse potential compared to oxycodone.

Read More »

Puma Biotech Surges After the FDA Officially Approves Breast Cancer Drug

The FDA approved Puma Biotechnology’s breast cancer drug Nerlynx (neratinib).

Read More »

Gottlieb Lays Out Plans to Attract and Preserve Top Talent at the FDA

The FDA is tackling a new way to recruit top talent — talent that will fill a “substantial” number of vacant position.

Read More »

Takeda Axes Sales Jobs, Forces Hundreds of Employees to Relocate to Boston

July 18, 2017 By Mark Terry, Breaking News Staff Chicago, Ill. – Takeda Pharmaceuticals (TKPYY) is shifting hundreds of executives from the Chicago area to relocate to Boston. It is also cutting hundreds of field sales positions throughout the U.S.   In March, the company indicated it was making job cuts in the Cambridge, […]

Read More »

Dengue kills 21 in Indian tourist hotspot, crisis looms

THIRUVANANTHAPURAM, India (Reuters) – A dengue outbreak has killed at least 21 people in India’s southern state of Kerala in the past three weeks, a government official said, adding that there was a shortage of medicines and health workers to tackle the crisis in the tourist hotspot. The mosquito-borne dengue virus, which causes flu-like symptoms […]

Read More »

More hospital closings in rural America add risk for pregnant women

By Jilian Mincer Bay Minette, Alabama (Reuters) – Dr. Nicole Arthur, a family practice physician, was trained to avoid Cesarean deliveries in child-birth, unless medically necessary, because surgery increases risks and recovery time. But she has adjusted her approach since arriving last year at the 70-bed North Baldwin Infirmary in rural, southern Alabama. Low patient […]

Read More »

U.S. Senate Republicans set repeal vote as healthcare overhaul sinks

  By Susan Cornwell   WASHINGTON (Reuters) – U.S. Senate Republicans will vote on a straight repeal of Obamacare after efforts to overhaul the law collapsed, rattling financial markets on Tuesday and clouding the path forward for President Donald Trump’s other domestic policy goals. After two Republicans said they would not back the latest Obamacare […]

Read More »

UDG Healthcare announces acquisition of Cambridge BioMarketing for up to $35M

UDG Healthcare plc announced the acquisition of Cambridge BioMarketing LLC, a U.S.-based healthcare communications business, for a total consideration of up to $35 million.

Read More »

Artificial sweeteners may not be risk free

People hoping to lose a few pounds by substituting artificial sweeteners for regular sugar may end up disappointed, suggests a fresh look at past research.

Read More »

Fingerpaint Taps Accomplished Duo to Lead Creative Team

Fingerpaint, a full-service marketing agency with offices in Arizona, Pennsylvania, New York and Ohio, named a longtime creative duo as the new leaders of the agency’s creative team. Katie Beller and Andy Spitzer will be based in the agency’s headquarters in Saratoga Springs, New York.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom